Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
08/1999
08/25/1999CN1226823A Pharmaceutical composition comprising coenzyme Q10
08/25/1999CN1226803A Diphenyl heterocycles as potassium channel modulators
08/24/1999US5942631 Inhibitors of cholesterol esterase
08/24/1999US5942622 Novel compounds for treating illness resulting from abnormal stimulation of endothelial receptors; for example: 4-((6-chloro-1,3-benzodioxol-5-yl)methyl)-1-(cyclohexylmethyl) -3-(2-pyridinyl)-1h-pyrazole-5-carboxylate
08/24/1999US5942550 Cholesterol lowering drink mix compositions
08/24/1999US5942536 Useful for treating migraine
08/24/1999US5942535 a!-Annelated pyrrole derivatives and pharmaceutical use thereof
08/24/1999US5942531 Phenolic/naphtholic retinoids for promoting skin/exoskeleton pigmentation
08/24/1999US5942524 Serotonin(5-ht-1) agonists
08/24/1999US5942523 Compounds which are selective antagonists of the human NK3 receptor and their use as medicinal products and diagnostic tools
08/24/1999US5942517 Antagonist of alpha(1c) receptors; treatment of benign prostatic hyperplasia
08/24/1999US5942516 Endothelin receptor antagonists
08/24/1999US5942514 Tyrosine kinase inhibitors
08/24/1999US5942513 Administering with diuretic suppresses efflux of antagonist through the blood-brain barrier increasing the duration of action and magnitude of effect of antagonist; treatment of stroke, schizophrenia, anxiety; antiepileptic agents
08/24/1999US5942511 Allylthiopyridazine derivatives and process for preparing the same
08/24/1999US5942502 Method of treating diseases resulting from calcium metabolism disorders
08/24/1999US5942499 Method of promoting bone growth with hyaluronic acid and growth factors
08/24/1999US5942497 Purine compound and catecholamine compound containing compositions and methods for administration
08/24/1999US5942496 Methods and compositions for multiple gene transfer into bone cells
08/24/1999US5942434 Regulatory sequence from phophoglycerate kinase operably linked to coding sequence of exogenous gene; for gene therapy; in situ expression of enzymes which convert prodrugs to active anticarcinogenic/antitumor drugs or cytokines
08/24/1999US5942419 RsbW-1 encoding nucleic acids
08/24/1999US5942241 A sustained release drug containing a substrate comprising a local anesthetic and a biocompatible, biodegradable, controlled release polymer selected from polyanhydrides, lactic acid and glycolic acid homo-or/and copolymers
08/24/1999US5942231 Daily bathing in a bathtub with a water-permeable bag containing the dry powder of guava leaves; treatment of allergic diseases
08/24/1999US5942225 Comprising the stem cells and one or more bioactive factors for inducing differentiation of them into a single particular lineage, e.g. bone, muscle, tendon, ligament, connective tissue cells
08/24/1999CA2248972A1 Novel compounds
08/24/1999CA2193348C Substituted alkyldiamine derivatives and their use as tachykinin antagonists
08/24/1999CA2176974C Phenyl heterocycles as cyclooxygenase-2 inhibitors
08/24/1999CA2015197C Phenolic amine depigmenting and antimelanoma agents
08/24/1999CA1340715C Bovine interleukin-1b
08/20/1999CA2249653A1 Novel compounds
08/19/1999WO1999041411A2 Method for diagnosis and treatment of disorders of carbohydrate metabolism
08/19/1999WO1999041377A1 Novel cystine knot protein and materials and methods for making it
08/19/1999WO1999041376A2 Retinoblastoma protein complexes and retinoblastoma interacting proteins
08/19/1999WO1999041374A2 Human short-chain tnf-receptor family protein
08/19/1999WO1999041373A2 Human transport-associated molecules
08/19/1999WO1999041363A1 Podocalyxin like sialomucins having selectin ligand activity
08/19/1999WO1999041285A1 Treating and diagnosing macrophage-mediated diseases using fc receptor ligands
08/19/1999WO1999041283A1 Pf4 fragments and pharmaceutical compositions containing same
08/19/1999WO1999041276A1 β-SHEET MIMETICS AND METHODS RELATING TO THE USE THEREOF
08/19/1999WO1999041269A1 Oligodeoxyribonucleotides comprising o6-benzylguanine and their use
08/19/1999WO1999041258A1 Novel dimerizing agents, their production and use
08/19/1999WO1999041257A1 Glucocorticoid-selective antiinflammatory agents
08/19/1999WO1999041251A1 Antagonists of gonadotropin releasing hormone
08/19/1999WO1999041248A1 Condensed heterocyclic system derivatives, preparation, pharmaceutical compositions containing them
08/19/1999WO1999041246A1 Novel cyclic sulfonamide derivatives as metalloproteinase inhibitors
08/19/1999WO1999041241A1 Heterocyclic topoisomerase poisons
08/19/1999WO1999041240A1 3,4-dihydroquinoline derivatives as nitrogen monoxide synthase (nos) inhibitors
08/19/1999WO1999041235A1 Farnesyl transferase inhibitors
08/19/1999WO1999041224A1 Biaryl-acetic acid derivatives and their use as cox-2 inhibitors
08/19/1999WO1999040946A2 Methods and compositions for modulating leptin activity
08/19/1999WO1999040944A2 Hydroxylation activated drug release
08/19/1999WO1999040931A1 Cyclic dipeptides and azetidinone compounds and their use in treating cns injury and neurodegenerative disorders
08/19/1999WO1999040925A2 Hapten-modified tumor cell membranes and their use
08/19/1999WO1999040914A1 Bicyclic pyrrole derivatives as mcp-1 inhibitors
08/19/1999WO1999040913A1 Chemical compounds
08/19/1999WO1999040867A1 Treatment of brain edema using carbonic anhydrase enzyme inhibitor
08/19/1999WO1999040783A1 Method of controlling proliferation and differentiation of stem and progenitor cells
08/19/1999WO1999032098A3 Combination of a ramba and a tocopherol
08/19/1999WO1999030670A3 Methods of treatment using novel ligands of the neuropeptide receptor hfgan72 and agonists or antagonists thereof
08/19/1999WO1999024451A3 Adenosine a1 receptor agonists
08/19/1999WO1999024449A3 Adenosine a1 receptor agonists
08/19/1999WO1999024076A3 Salicylate derivatized therapeutic and diagnostic agents
08/19/1999WO1999024074A3 Novel conjugates of opioids and endogenous carriers
08/19/1999WO1999024058A3 Neuronal uses of bmp-11
08/19/1999WO1999024024A3 Treatment of t-helper cell type 2 mediated immune diseases with retinoid antagonists
08/19/1999WO1999023227A3 Hyaluronan synthase gene and uses thereof
08/19/1999WO1999021845A3 4-aminothiazole derivatives, their preparation and their use as inhibitors of cyclin-dependent kinases
08/19/1999WO1999015894A3 Method of identification of leads or active compounds
08/19/1999WO1999004266A3 Interactions of atm, atr or dna-pk with p53
08/19/1999WO1999001416A3 1-amino-alkylcyclohexane nmda receptor antagonists
08/19/1999WO1998030590A9 Analogs of parathyroid hormone
08/19/1999DE19806438A1 New pyrimidinyloxy-propionic acid derivatives useful as endothelin receptor antagonists in treatment of e.g. cardiac insufficiency, restenosis, hypertension, kidney failure, asthma and prostate cancer
08/19/1999DE19806348A1 3,4-Dihydrochinolin-Derivate und ihre Verwendung in Arzneimitteln 3,4-dihydroquinoline derivatives and their use in medicaments
08/19/1999DE19802377A1 Verwendung von Inhibitoren für die Behandlung von RTK-Überfunktions-bedingten Störungen, insbesondere von Krebs Use of inhibitors for the treatment of RTK function-related disorders, particularly cancer
08/19/1999CA2321218A1 Condensed heterocyclic system derivatives, preparation, pharmaceutical compositions containing them
08/19/1999CA2321136A1 Treating and diagnosing macrophage-mediated diseases using fc receptor ligands
08/19/1999CA2321105A1 Human short-chain tnf-receptor family protein
08/19/1999CA2320969A1 Hapten-modified tumor cell membranes, and methods of making and using hapten-modified tumor cell membranes
08/19/1999CA2320934A1 Treatment of brain edema using carbonic anhydrase inhibitor
08/19/1999CA2320911A1 Glucocorticoid-selective anti-inflammatory agents
08/19/1999CA2320424A1 Human transport-associated molecules
08/19/1999CA2320391A1 Novel cystine knot protein and materials and methods for making it
08/19/1999CA2320378A1 Cyclic dipeptides and azetidinone compounds and their use in treating cns injury and neurodegenerative disorders
08/19/1999CA2320226A1 Methods and compositions for modulating leptin activity
08/19/1999CA2319782A1 Retinoblastoma protein complexes and retinoblastoma interacting proteins
08/19/1999CA2319766A1 .beta.-sheet mimetics and methods relating to the use thereof
08/19/1999CA2319492A1 Novel dimerizing agents, their production and use
08/19/1999CA2319173A1 Novel cyclic sulfonamide derivatives as metalloproteinase inhibitors
08/19/1999CA2319082A1 Bicyclic pyrrole derivatives as mcp-1 inhibitors
08/19/1999CA2319065A1 Method for diagnosis and treatment of disorders of carbohydrate metabolism
08/19/1999CA2318966A1 Biaryl-acetic acid derivatives and their use as cox-2 inhibitors
08/19/1999CA2318347A1 Heterocyclic topoisomerase poisons
08/19/1999CA2318068A1 Podocalyxin like sialomucins having selectin ligand activity
08/19/1999CA2317456A1 Chemical compounds
08/19/1999CA2317451A1 Antagonists of gonadotropin releasing hormone
08/18/1999EP0936221A1 Novel 2,4-dioxopyrrolidine and 2,4-dioxotetrahydrofuran derivatives and medicines containing the same as the active ingredient
08/18/1999EP0935963A2 The use of MMP-13 selective inhibitors for the treatment of osteoarthritis and other matrix metalloproteinase-mediated disorders
08/18/1999EP0935656A1 Hedgehog interacting proteins and uses related thereto
08/18/1999EP0935655A1 Methods and reagents for discovering and using mammalian melanocortin receptor agonists and antagonists to modulate feeding behavior in animals
08/18/1999EP0935652A1 Keratinocyte growth factor-2 products
1 ... 1217 1218 1219 1220 1221 1222 1223 1224 1225 1226 1227 1228 1229 1230 1231 1232 1233 1234 1235 1236 1237 ... 1564